NOF Corporation Makes Strategic Minority Investment in Phosphorex

August 9, 2024

Japanese chemical manufacturer NOF Corporation completed a strategic minority investment in Phosphorex, a Hopkinton, Massachusetts-based drug-delivery CDMO backed by Ampersand Capital Partners. The investment will fund acceleration of Phosphorex's cGMP capabilities and strengthen collaboration on lipid nanoparticle (LNP) technologies and NOF's COATSOME SS series ionizable lipids.

Buyers
NOF CORPORATION
Targets
Phosphorex
Industry
Pharmaceuticals
Location
Massachusetts, United States
Transaction Type
Growth capital

Explore More

Related articles

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.

Find buyers like these →